Immediate Impact
6 from Science/Nature 59 standout
Citing Papers
Pancreatic cancer: Advances and challenges
2023 Standout
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
2020 Standout
Works of James D. Ahlgren being referenced
Epidemiology and risk factors in pancreatic cancer.
1996
Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program.
1993
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| James D. Ahlgren | 1131 | 359 | 190 | 341 | 36 | 1.4k | |
| Fred J. Ansfield | 1007 | 475 | 156 | 416 | 50 | 1.8k | |
| M Forni | 1084 | 453 | 122 | 293 | 39 | 1.8k | |
| G Brufman | 1307 | 433 | 69 | 342 | 38 | 1.8k | |
| Robert M. OʼBryan | 956 | 634 | 150 | 300 | 43 | 1.5k | |
| Mukund S. Didolkar | 941 | 656 | 153 | 580 | 59 | 1.8k | |
| Rut Isacson | 1256 | 433 | 67 | 333 | 22 | 1.9k | |
| G.J. Creemers | 1064 | 387 | 91 | 461 | 46 | 1.5k | |
| James A. Knost | 752 | 301 | 90 | 297 | 45 | 1.6k | |
| Kurt Brunner | 808 | 444 | 197 | 495 | 81 | 1.7k | |
| G. Comella | 958 | 425 | 74 | 202 | 69 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...